Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Roelien H, Enting"'
Autor:
Hiska L. van der Weide, Justyna Kłos, Johannes A. Langendijk, Charlotte L. Brouwer, Peter F. Sinnige, Ronald J.H. Borra, Rudi A.J.O. Dierckx, Rients B. Huitema, Sandra E. Rakers, Anne M. Buunk, Jacoba M. Spikman, Ingeborg B. Bosma, Roelien H. Enting, Merethe Blandhol, Roland K. Chiu, Anouk van der Hoorn, Miranda C.A. Kramer
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 33, Iss , Pp 99-105 (2022)
Aim: To investigate the clinical relevance of the radiotherapy (RT) dose bath in patients treated for lower grade glioma (LGG). Methods: Patients (n = 17) treated with RT for LGG were assessed with neurocognitive function (NCF) tests and structural M
Externí odkaz:
https://doaj.org/article/04b36663b9244c0383d8b3a4e47d2db3
Autor:
Jesse D de Groot, Bart R J van Dijken, Hiska L van der Weide, Roelien H Enting, Anouk van der Hoorn
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0275077 (2023)
BackgroundRadiotherapy (RT) and chemotherapy are components of standard multi-modality treatment of high grade gliomas (HGG) aimed at achieving local tumor control. Treatment is neurotoxic and RT plays an important role in this, inducing damage even
Externí odkaz:
https://doaj.org/article/44bcde16c76b47849a4344b62bf293f8
Autor:
Bart R. J. van Dijken, Hanne-Rinck Jeltema, Justyna Kłos, Peter Jan van Laar, Roelien H. Enting, Ronald G. H. J. Maatman, Klaas Bijsterveld, Wilfred F. A. Den Dunnen, Rudi A. Dierckx, Paul E. Sijens, Anouk van der Hoorn
Publikováno v:
Diagnostics, Vol 13, Iss 17, p 2791 (2023)
Isocitrate dehydrogenase (IDH) mutation status is an important biomarker in the glioma-defining subtype and corresponding prognosis. This study proposes a straightforward method for 2-hydroxyglutarate (2-HG) quantification by MR spectroscopy for IDH
Externí odkaz:
https://doaj.org/article/88d6706036dd49d38b2cb0651fcfd264
Autor:
Stefan Both, Johannes A. Langendijk, A. Bannink-Gawryszuk, M. Landeweerd, Roelien H. Enting, D. Scandurra, H van der Weide, Ingeborg Bosma, Miranda C. A. Kramer, Mart A. A. M. Heesters
Publikováno v:
Radiotherapy and Oncology. 161:S103-S105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::779e8e15d6f376bfe327bf9766e521c4
https://doi.org/10.1016/s0167-8140(21)07261-3
https://doi.org/10.1016/s0167-8140(21)07261-3
Autor:
Wilfred F. A. den Dunnen, Roelien H. Enting, Reina W. Kloet, Hanne-Rinck Jeltema, Wilfried W. H. Roeloffzen, Jorrit De Vries, Marinus D.L.M. Oterdoom
Publikováno v:
World neurosurgery, 142, 227-232. ELSEVIER SCIENCE INC
BACKGROUND: T-cell lymphoblastic lymphoma (T-LBL) is a rare and aggressive form of non-Hodgkin lymphoma. This report describes, to our knowledge, the first adult case of a primary cauda equina T-LBL. Treatment consists of multiagent chemotherapy, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b0100f7ffd83c2aa38e0dc453bcd03e
https://research.rug.nl/en/publications/1a40196a-e0e3-4db7-945a-101c3d78aea1
https://research.rug.nl/en/publications/1a40196a-e0e3-4db7-945a-101c3d78aea1
Autor:
Bart R. J. van Dijken, Hanne-Rinck Jeltema, Rudi Dierckx, Anouk van der Hoorn, Roelien H. Enting, Gilles N. Stormezand, Bram Schuuring, Peter Jan van Laar
Publikováno v:
Neuroradiology, 64, 247-252. SPRINGER
Neuroradiology
Neuroradiology
Purpose Ventricle contact is associated with a worse prognosis and more aggressive tumor characteristics in glioblastoma (GBM). This is hypothesized to be a result of neural stem cells located around the lateral ventricles, in the subventricular zone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa060c987c78e73bea53971533b40d57
https://research.rug.nl/en/publications/48082341-37f3-4fa4-a870-3b3d14747966
https://research.rug.nl/en/publications/48082341-37f3-4fa4-a870-3b3d14747966
Autor:
Anouk van der Hoorn, Chris W. Govaerts, Gilles N. Stormezand, Roelien H. Enting, Hiske L. van der Weide, Michiel Wagemakers, Bart R. J. van Dijken
Publikováno v:
British journal of radiology, 94(1125):20210275. BRITISH INST RADIOLOGY
Objectives: Radiation-induced changes (RIC) secondary to focal radiotherapy can imitate tumour progression in brain metastases and make follow-up clinical decision making unreliable. 11C-methyl-L-methionine-PET (MET-PET) is widely used for the diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3302c4e5ed84e91cbfbfa2dbf2a667b
https://doi.org/10.1259/bjr.20210275
https://doi.org/10.1259/bjr.20210275
Autor:
Martin J. van den Bent, Gavin Cull, Marion Smits, Samar Issa, Hakim C. Achterberg, Jacoline E C Bromberg, Max Beijert, Josée M. Zijlstra, Jeanette K. Doorduijn, Katerina Bakunina, Martin J B Taphoorn, Harry C. Schouten, Tatjana Seute, Matthijs van der Meulen, Esther J. J. Habets, Dieta Brandsma, Linda Dirven, Roelien H. Enting
Publikováno v:
Neuro-Oncology, 23(8), 1315-1326. Oxford University Press
Neuro-Oncology, 23(8), 1315-1326. OXFORD UNIV PRESS INC
Neuro Oncol
Neuro-oncology, 23(8), 1315-1326. Oxford University Press
van der Meulen, M, Dirven, L, Habets, E J J, Bakunina, K, Smits, M, Achterberg, H C, Seute, T, Cull, G, Schouten, H, Zijlstra, J M, Brandsma, D, Enting, R H, Beijert, M, Taphoorn, M J B, van den Bent, M J, Issa, S, Doorduijn, J K & Bromberg, J E C 2021, ' Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: Results from the HOVON 105/ALLG NHL 24 randomized controlled trial ', Neuro-Oncology, vol. 23, no. 8, pp. 1315-1326 . https://doi.org/10.1093/neuonc/noab021
Neuro-Oncology, 23(8), 1315-1326. OXFORD UNIV PRESS INC
Neuro Oncol
Neuro-oncology, 23(8), 1315-1326. Oxford University Press
van der Meulen, M, Dirven, L, Habets, E J J, Bakunina, K, Smits, M, Achterberg, H C, Seute, T, Cull, G, Schouten, H, Zijlstra, J M, Brandsma, D, Enting, R H, Beijert, M, Taphoorn, M J B, van den Bent, M J, Issa, S, Doorduijn, J K & Bromberg, J E C 2021, ' Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: Results from the HOVON 105/ALLG NHL 24 randomized controlled trial ', Neuro-Oncology, vol. 23, no. 8, pp. 1315-1326 . https://doi.org/10.1093/neuonc/noab021
Background To analyze the effect of treatment on neurocognitive functioning and the association of neurocognition with radiological abnormalities in primary central nervous system lymphoma (PCNSL). Methods One hundred and ninety-nine patients from a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88304e0b91e48d1ebefb3d9b24ccf859
https://doi.org/10.1093/neuonc/noab021
https://doi.org/10.1093/neuonc/noab021
Autor:
Siobhan Conroy, Frank A E Kruyt, Justin V Joseph, Veerakumar Balasubramaniyan, Krishna P Bhat, Michiel Wagemakers, Roelien H Enting, Annemiek M E Walenkamp, Wilfred F A den Dunnen
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115687 (2014)
Molecular signatures in Glioblastoma (GBM) have been described that correlate with clinical outcome and response to therapy. The Proneural (PN) and Mesenchymal (MES) signatures have been identified most consistently, but others including Classical (C
Externí odkaz:
https://doaj.org/article/026749e0cbcc49509bcba8d7ea8576c6
Autor:
Jean Francais Baurain, Brigitta G. Baumert, Paul Mulholland, Sanjeev Gill, Iris de Heer, Wies Vallentgoed, Pim J. French, Michael A. Vogelbaum, Anja Gijtenbeek, Michael Weller, Francesca Caparrotti, Judith V.M.G. Bovée, Wolfgang Wick, Thierry Gorlia, Paul Clement, Sanne Venneker, Martin J. van den Bent, Leland Rogers, Pieter Wesseling, C Mircea S Tesileanu, Johan M. Kros, Roberta Rudà, Vassilis Golfinopoulos, Martin J B Taphoorn, Matthew E. Griffin, Hendrikus J. Dubbink, Youri Hoogstrate, Olivier Chinot, Jaap C. Reijneveld, Alba A. Brandes, Warren P. Mason, Roelien H. Enting, Sara Erridge, Susan Clenton, Thierry Lesimple, Lorenzo Boggiani, Anna K. Nowak, Kenneth Aldape, Marc Sanson, Jan Oosting, Walter Taal, Robert B. Jenkins, Filip de Vos, Elizabeth Lim, Catherine McBain, Helen Wheeler, Maurice de Wit
Publikováno v:
Acta Neuropathologica, 141(6), 945-957. SPRINGER
Acta Neuropathologica, 141(6), 945-957. Springer, Cham
Acta Neuropathologica
Acta Neuropathologica, 2021, 141 (6), pp.945-957. ⟨10.1007/s00401-021-02291-6⟩
Acta Neuropathologica, 141, 6, pp. 945-957
Acta Neuropathologica, 141(6), 945-957. Springer Verlag
Acta Neuropathologica, Springer Verlag, 2021, 141 (6), pp.945-957. ⟨10.1007/s00401-021-02291-6⟩
Tesileanu, C M S, Vallentgoed, W R, Sanson, M, Taal, W, Clement, P M, Wick, W, Brandes, A A, Baurain, J F, Chinot, O L, Wheeler, H, Gill, S, Griffin, M, Rogers, L, Rudà, R, Weller, M, McBain, C, Reijneveld, J, Enting, R H, Caparrotti, F, Lesimple, T, Clenton, S, Gijtenbeek, A, Lim, E, de Vos, F, Mulholland, P J, Taphoorn, M J B, de Heer, I, Hoogstrate, Y, de Wit, M, Boggiani, L, Venneker, S, Oosting, J, Bovée, J V M G, Erridge, S, Vogelbaum, M A, Nowak, A K, Mason, W P, Kros, J M, Wesseling, P, Aldape, K, Jenkins, R B, Dubbink, H J, Baumert, B, Golfinopoulos, V, Gorlia, T, van den Bent, M & French, P J 2021, ' Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations ', Acta Neuropathologica, vol. 141, no. 6, pp. 945-957 . https://doi.org/10.1007/s00401-021-02291-6
Acta Neuropathologica, 141, 945-957
Acta neuropathologica, Vol. xx, no.xx, p. xx (2021)
Acta Neuropathologica, 141(6), 945-957. Springer-Verlag
Acta Neuropathologica, 141(6), 945-957. Springer, Cham
Acta Neuropathologica
Acta Neuropathologica, 2021, 141 (6), pp.945-957. ⟨10.1007/s00401-021-02291-6⟩
Acta Neuropathologica, 141, 6, pp. 945-957
Acta Neuropathologica, 141(6), 945-957. Springer Verlag
Acta Neuropathologica, Springer Verlag, 2021, 141 (6), pp.945-957. ⟨10.1007/s00401-021-02291-6⟩
Tesileanu, C M S, Vallentgoed, W R, Sanson, M, Taal, W, Clement, P M, Wick, W, Brandes, A A, Baurain, J F, Chinot, O L, Wheeler, H, Gill, S, Griffin, M, Rogers, L, Rudà, R, Weller, M, McBain, C, Reijneveld, J, Enting, R H, Caparrotti, F, Lesimple, T, Clenton, S, Gijtenbeek, A, Lim, E, de Vos, F, Mulholland, P J, Taphoorn, M J B, de Heer, I, Hoogstrate, Y, de Wit, M, Boggiani, L, Venneker, S, Oosting, J, Bovée, J V M G, Erridge, S, Vogelbaum, M A, Nowak, A K, Mason, W P, Kros, J M, Wesseling, P, Aldape, K, Jenkins, R B, Dubbink, H J, Baumert, B, Golfinopoulos, V, Gorlia, T, van den Bent, M & French, P J 2021, ' Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations ', Acta Neuropathologica, vol. 141, no. 6, pp. 945-957 . https://doi.org/10.1007/s00401-021-02291-6
Acta Neuropathologica, 141, 945-957
Acta neuropathologica, Vol. xx, no.xx, p. xx (2021)
Acta Neuropathologica, 141(6), 945-957. Springer-Verlag
Somatic mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 occur at high frequency in several tumour types. Even though these mutations are confined to distinct hotspots, we show that gliomas are the only tumour type with an exceptionally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e803a4e103567d640cfaa40e7a6f1f4a
https://link.springer.com/content/pdf/10.1007/s00401-021-02291-6.pdf
https://link.springer.com/content/pdf/10.1007/s00401-021-02291-6.pdf